Improved Prediction of Survival by a Risk Factor-Integrating Inflammatory Score in Sorafenib-Treated Hepatocellular Carcinoma

BACKGROUND AND AIMS: Inflammation affects progression of hepatocellular carcinoma (HCC). We therefore postulate that systemic inflammatory markers could help to predict prognosis in HCC patients receiving sorafenib therapy. METHODS: Overall survival (OS) of HCC patients receiving palliative sorafeni...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Liver Cancer
Autors principals: Sprinzl, Martin F., Kirstein, Martha M., Koch, Sandra, Seib, Marie-Luise, Weinmann-Menke, Julia, Lang, Hauke, Düber, Christoph, Toenges, Gerrit, Zöller, Daniela, Marquardt, Jens U., Wörns, Marcus-Alexander, Galle, Peter R., Vogel, Arndt, Pinter, Matthias, Weinmann, Arndt
Format: Artigo
Idioma:Inglês
Publicat: S. Karger AG 2019
Matèries:
Original Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6873091/
https://ncbi.nlm.nih.gov/pubmed/31768347
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000492628
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars